CGMP level that reduces cardiac myocyte O2 consumption is altered in renal hypertension

American Journal of Physiology

Volumn 273, Issue 4 PART 2, 1997, Pages

  Straznicka, Michaela ^a   Gong, Gary ^b   Tse, James ^a   Scholz, Peter M ^b   Weiss, Harvey R ^a  

^a University of Medicine   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Cardiac hypertrophy; Guanosine 3 ,5 cyclic monophosphate; Guanylate cyclase; Oxygen consumption

Indexed keywords

EID: 20644437086     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.273.4.h1949     Document Type: Article

References (27)

1. Brune, B., K. U. Schmidt, and V. Ullrich. Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion. Eur. J. Biochem. 192: 683-688,1990.
2. 2 supply and consumption in early cardiac hypertrophy of renal hypertensive rabbits. Basic Res. Cardiol. 84:13-21,1989.
3. Currie, M. G., K. F. Fok, J. Kato, R. J. Moore, F. K. Hamra, K. L. Duffin, and C. E. Smith. Guanylin: an endogenous activator of intestinal guanylate cyclase. Proc. Natl. Acad. Sei. USA 89: 947-951,1992.
4. Dowell, R. T., J. L. Haithcoat, H. M. Thirkill, and W. K. Palmer. Heart cyclic nucleotide responses to sustained aortic constriction in neonatal and adult rat. Am. J. Physiol. 246 (Heart Circ. Physiol. 15): H197-H206,1984.
5. Garbers, D. L. Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands. Cell 71:1-4,1992.
6. Gong, X., P. Kodandaram, G. L. Florant, and R. L. White. Fatty acid modified diet alters sarcolemmal fatty acids and temperature dependence of ventricular calcium current kinetics in a hibernator. In: International Hibernation Symposium (III), edited by G. L. Florant. New York: Plenum, 1994, p. 16-23.
7. Gong, G. X., H. R. Weiss, J. Tse, and P. M. Scholz. Cyclic GMP decreases cardiac myocyte oxygen consumption to a greater extent under conditions of increased metabolism. J Cardiovasc. Pharmacol. In press.
8. Jakob, G., J. Mair, M. Pichler, and B. Puschendorf. Ergometric exercise testing and sensitivity of cyclic guanosine 3′,5′monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction. Br. Heart J. 73:145-150,1995.
9. Kimura, H., C. K. Mittal, and F. Murad. Activation of guanylate cyclase from rat liver and other tissues by sodium azide. J. Biol. Chem. 250: 8016-8022,1975.
10. Kimura, H., and F. Murad. Evidence for two different forms of guanylate cyclase in rat heart. J. Biol. Chem. 249: 6910-6916, 1974.
11. Kojda, G., K. Kottenberg, P. Nix, K. D. Schluter, H. M. Piper, and E. Noack. Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ. Res. 78: 91-101,1996.
12. Lohmann, S. M., R. Fischmeister, and U. Walter. Signal transduction by cGMP in heart. Basic Res. Cardiol. 86: 503-514, 1991.
13. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc. Natl. Acad. Sei. USA 88:1197-1201,1991.
14. Murad, F. The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication. Recent Prog. Harm. Res. 49: 239-248,1994.
15. Nawrath, H., D. Baumner, J. Rupp, and H. Oelert. The ineffectiveness of the NO-cyclic GMP signaling pathway in the atrial myocardium. Br. J. Pharmacol. 116: 3061-3067,1995.
16. Nichols, J. R., and N. C. Gonzalez. Increase in myocardial cell cGMP concentration in pressure-induced myocardial hypertrophy. J. Mol. Cell. Cardiol. 14:181-18 1982.
17. Rabindranauth, P., K. L. Nairn, P. M. Scholz, J. Tse, J. D. Sadoff, and H. R. Weiss. Negative metabolic effects of cyclic GMP are altered in renal hypertension induced cardiac hypertrophy. Basic Res. Cardiol. 92: 8-16,1997.
18. Roitstein, A., J. Kedem, B. Cheinberg, H. R. Weiss, J. Tse, and P. M. Scholz. The effect of intracoronary nitroprusside on cyclic GMP and regional mechanics is altered in a canine model of left ventricular hypertrophy. J. Surg. Res. 57: 584-590,1994.
19. Rumsey, W. L., C. Schlosser, E. M. Nuutinen, M. Robiolio, and D. F. Wilson. Cellular energetics and the oxygen dependence of respiration in cardiac myocytes isolated from adult rat. J. Biol. Chem. 265: 15392-15402,1990.
20. Schmidt, H. H., S. M. Lohmann, and U. Walter. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim. Biophys. Acta 1178: 153-175, 1993.
21. Shah, A. M., H. A. Spurgeon, S. J. Sollott, A. Talo, and E. G. Lakatta. 8-Bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes. Circ. Res. 74: 970-978,1994.
22. Sperelakis, N., N. Tohse, Y. Ohya, and H. Masuda. Cyclic GMP regulation of calcium slow channels in cardiac muscle and vascular smooth muscle cells. Adv. Pharmacol. 26: 217-252, 1994.
23. 2+ channel activity by human natriuretic peptide in rabbit heart cells. Br. J. Pharmacol. 114:1076-1082,1995.
24. Waldman, S. A., and F. Murad. Cyclic GMP synthesis and function. Pharmacol. Rev. 39:163-196,1987.
25. 2 supply? In: Imaging, Measurements, and Analysis of the Heart, edited by S. Sideman and R. Beyar. New York: Hemisphere, 1993, p. 299-321.
26. 4-induced cardiac hypertrophy. Am. J. Physiol. 268 (Heart Cire. Physiol. 37):H686-H691,1995.
27. Weiss, H. R., E. Rodriguez, J. Tse, and P. M. Scholz. Effect of increased myocardial cyclic GMP induced by cyclic GMPphosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts. Clin. Exp. Pharmacol. Physiol. 21: 607-614, 1994.